Meiji Yasuda Life Insurance CO Regeneron Pharmaceuticals, Inc. Transaction History

Meiji Yasuda Life Insurance CO

$5.29 Billion
Q4 2024

A detailed history of Meiji Yasuda Life Insurance CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Meiji Yasuda Life Insurance CO holds 872 shares of REGN stock, worth $630,865. This represents 0.01% of its overall portfolio holdings.

Number of Shares

872

Previous 872 -0.0%

Holding current value

$630,865

Previous $916,000 32.21%

% of portfolio

0.01%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1024.09 - $1201.76 $20,481 - $24,035	-20 Reduced 2.24%	872 $916,000
Q2 2024 Aug 12, 2024	SELL	$883.2 - $1071.19 $2.3 Million - $2.79 Million	-2,609 Reduced 74.52%	892 $937,000
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $473,912 - $521,508	525 Added 17.64%	3,501 $3.37 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $486,813 - $553,707	628 Added 26.75%	2,976 $2.61 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $410,622 - $500,711	593 Added 33.79%	2,348 $1.93 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $13,300 - $15,776	19 Added 1.09%	1,755 $1.26 Million
Q1 2023 May 10, 2023	SELL	$680.49 - $826.97 $3,402 - $4,134	-5 Reduced 0.29%	1,736 $1.43 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $2,823 - $3,065	4 Added 0.23%	1,741 $1.26 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $26,402 - $33,318	-46 Reduced 2.58%	1,737 $1.2 Million
Q2 2022 Aug 16, 2022	BUY	$548.35 - $738.84 $160,118 - $215,741	292 Added 19.58%	1,783 $1.05 Million
Q1 2022 May 17, 2022	SELL	$595.12 - $698.43 $68,438 - $80,319	-115 Reduced 7.16%	1,491 $1.04 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $163,587 - $201,961	301 Added 23.07%	1,606 $1.01 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $17,220 - $20,428	30 Added 2.35%	1,305 $790,000
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $263,065 - $334,389	-550 Reduced 30.14%	1,275 $616,000
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $3,813 - $4,607	7 Added 0.39%	1,825 $1.02 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $1,973 - $2,575	4 Added 0.22%	1,818 $1.13 Million
Q1 2020 May 14, 2020	SELL	$336.18 - $494.43 $140,523 - $206,671	-418 Reduced 18.73%	1,814 $886,000
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $105,540 - $144,956	385 Added 20.84%	2,232 $838,000
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $326,264 - $451,738	-1,089 Reduced 37.09%	1,847 $578,000
Q1 2019 May 14, 2019	SELL	$372.08 - $439.57 $162,598 - $192,092	-437 Reduced 12.96%	2,936 $1.21 Million
Q4 2018 Feb 12, 2019	BUY	$335.82 - $403.04 $77,238 - $92,699	230 Added 7.32%	3,373 $1.26 Million
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $351,140 - $408,510	1,000 Added 46.66%	3,143 $1.27 Million
Q4 2017 Feb 13, 2018	SELL	$358.63 - $469.95 $71,726 - $93,990	-200 Reduced 8.54%	2,143 $806,000
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $1.01 Million - $1.18 Million	2,343	2,343 $1.05 Million

Others Institutions Holding REGN

# of Institutions

1,488

Shares Held

85.7M

Call Options Held

1.53M

Put Options Held

1.44M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $77.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meiji Yasuda Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Meiji Yasuda Life Insurance CO with notifications on news.

Account

Meiji Yasuda Life Insurance CO Regeneron Pharmaceuticals, Inc. Transaction History